血管内成像指导冠状动脉药物洗脱支架置入:更新的网络Meta分析
该更新的系统评价与网络Meta分析纳入22项随机试验、15 964例接受药物洗脱支架PCI的患者,比较血管内成像(血管内超声或光学相干断层扫描)指导与单纯造影指导。加权平均随访24.7个月(各研究最长随访6至60个月)。血管内成像指导使靶病变失败风险降低(RR 0.71 [95% CI 0.63-0.80];p<0.0001),并降低心源性死亡、靶血管心肌梗死、靶病变血运重建、支架血栓、全因心肌梗死和全因死亡风险。OCT指导与血管内超声指导的结局相似。
要点
- 血管内成像指导PCI降低靶病变失败风险:RR 0.71(95% CI 0.63-0.80;p<0.0001),驱动因素为心源性死亡、靶血管心肌梗死和靶病变血运重建。
- 血管内成像指导还降低支架血栓(RR 0.52 [95% CI 0.34-0.81];p=0.0036)、全因心肌梗死(RR 0.83 [95% CI 0.71-0.99];p=0.033)和全因死亡(RR 0.75 [95% CI 0.60-0.93];p=0.0091)。
- 心源性死亡风险降低:RR 0.55(95% CI 0.41-0.75;p=0.0001);靶血管心肌梗死:RR 0.82(95% CI 0.68-0.98;p=0.030);靶病变血运重建:RR 0.72(95% CI 0.60-0.86;p=0.0002)。
- OCT指导与血管内超声指导的结局相似。
适用人群与场景
- 接受经皮冠状动脉介入治疗(PCI)并置入药物洗脱支架的患者。
研究设计与关键结果
- 研究类型:系统评价与更新的网络Meta分析,纳入22项随机试验,共15 964例患者,加权平均随访24.7个月(各研究最长随访6至60个月)。
- 主要终点靶病变失败(心源性死亡、靶血管心肌梗死或靶病变血运重建的复合终点):血管内成像指导 vs 造影指导 RR 0.71(95% CI 0.63-0.80;p<0.0001)。
- 心源性死亡:RR 0.55(95% CI 0.41-0.75;p=0.0001);靶血管心肌梗死:RR 0.82(95% CI 0.68-0.98;p=0.030);靶病变血运重建:RR 0.72(95% CI 0.60-0.86;p=0.0002)。
- 支架血栓:RR 0.52(95% CI 0.34-0.81;p=0.0036);全因心肌梗死:RR 0.83(95% CI 0.71-0.99;p=0.033);全因死亡:RR 0.75(95% CI 0.60-0.93;p=0.0091)。
- OCT指导与血管内超声指导的结局相似。
证据类型、等级与局限
- 证据类型:系统评价与网络Meta分析(纳入随机试验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 与造影指导相比,血管内成像(OCT或血管内超声)指导冠状动脉支架置入可提高PCI的安全性和有效性,降低死亡、心肌梗死、重复血运重建和支架血栓风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Previous meta-analyses have shown reduced risks of composite adverse events with intravascular imaging-guided percutaneous coronary intervention (PCI) compared with angiography guidance alone. However, these studies have been insufficiently powered to show whether all-cause death or all myocardial infarction are reduced with intravascular imaging guidance, and most previous intravascular imaging studies were done with intravascular ultrasound rather than optical coherence tomography (OCT), a newer imaging modality. We aimed to assess the comparative performance of intravascular imaging-guided PCI and angiography-guided PCI with drug-eluting stents.
METHODS: For this systematic review and updated meta-analysis, we searched the MEDLINE, Embase, and Cochrane databases from inception to Aug 30, 2023, for studies that randomly assigned patients undergoing PCI with drug-eluting stents either to intravascular ultrasound or OCT, or both, or to angiography alone to guide the intervention. The searches were done and study-level data were extracted independently by two investigators. The primary endpoint was target lesion failure, defined as the composite of cardiac death, target vessel-myocardial infarction (TV-MI), or target lesion revascularisation, assessed in patients randomly assigned to intravascular imaging guidance (intravascular ultrasound or OCT) versus angiography guidance. We did a standard frequentist meta-analysis to generate direct data, and a network meta-analysis to generate indirect data and overall treatment effects. Outcomes were expressed as relative risks (RRs) with 95% CIs at the longest reported follow-up duration. This study was registered with the international prospective register of systematic reviews (PROSPERO, number CRD42023455662).
FINDINGS: 22 trials were identified in which 15 964 patients were randomised and followed for a weighted mean duration of 24·7 months (longest duration of follow-up in each study ranging from 6 to 60 months). Compared with angiography-guided PCI, intravascular imaging-guided PCI resulted in a decreased risk of target lesion failure (RR 0·71 [95% CI 0·63-0·80]; p<0·0001), driven by reductions in the risks of cardiac death (RR 0·55 [95% CI 0·41-0·75]; p=0·0001), TV-MI (RR 0·82 [95% CI 0·68-0·98]; p=0·030), and target lesion revascularisation (RR 0·72 [95% CI 0·60-0·86]; p=0·0002). Intravascular imaging guidance also reduced the risks of stent thrombosis (RR 0·52 [95% CI 0·34-0·81]; p=0·0036), all myocardial infarction (RR 0·83 [95% CI 0·71-0·99]; p=0·033), and all-cause death (RR 0·75 [95% CI 0·60-0·93]; p=0·0091). Outcomes were similar for OCT-guided and intravascular ultrasound-guided PCI.
INTERPRETATION: Compared with angiography guidance, intravascular imaging guidance of coronary stent implantation with OCT or intravascular ultrasound enhances both the safety and effectiveness of PCI, reducing the risks of death, myocardial infarction, repeat revascularisation, and stent thrombosis.
参考来源
- Stone GW, Christiansen EH, Ali ZA, et al. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Lancet. 2024. PMID: 38401549. doi:10.1016/S0140-6736(23)02454-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。